Immunovant Sciences Gmbh

This study tests a new medicine called IMVT-1402 for people with moderate to severe Sjögren's disease, an autoimmune condition causing dry eyes, dry mouth, and other symptoms. About 180 adults will receive either the drug or a placebo to see if it reduces disease activity over 24…

This study tests an investigational drug called IMVT-1402 in adults with chronic inflammatory demyelinating polyneuropathy (CIDP), a condition where the immune system attacks the nerves. The goal is to see if the drug can prevent relapses and improve strength and function. About …

This study tests an investigational drug called IMVT-1402 in people with active lupus skin disease (subacute or chronic cutaneous lupus). About 56 participants will receive either the drug or a placebo for 12 weeks, then all will get the drug for 14 more weeks, followed by a 26-w…

This study tests an investigational drug called IMVT-1402 in 231 adults with mild to severe generalized myasthenia gravis, a condition causing muscle weakness. Participants receive either the drug or a placebo to see if it improves daily activities and muscle strength. The goal i…

This study tests an experimental drug called IMVT-1402 in 210 adults with Graves' disease whose thyroid is still overactive despite standard medication. The goal is to see if the drug can help patients achieve normal thyroid levels and stop taking their current thyroid medication…

This study tests an experimental drug called IMVT-1402 for adults with Graves' disease whose thyroid is still overactive despite taking standard antithyroid medications. About 240 participants will receive either the drug or a placebo to see if it can bring thyroid hormone levels…